taurine

Overview

Taurine is a sulfur-containing organic compound, chemically known as 2-aminoethanesulfonic acid. In biomedical research, it is commonly discussed as a conditionally essential amino acid-like molecule with roles in osmoregulation, membrane stabilization, antioxidant defense, and modulation of inflammatory and metabolic pathways. Although it is not incorporated into proteins, taurine is widely studied for its physiological importance in tissues with high metabolic demand and in conditions involving oxidative stress, inflammation, and impaired cellular homeostasis.

As a therapeutic research entity, taurine has attracted attention in metabolic disease, tissue repair, and aging-related biology. Recent studies have examined its use as a supplement, a bioactive component in drug-delivery systems, and a mechanistic probe of signaling pathways such as HMGB1/TLR4/MyD88/NF-κB and p38 MAPK. These investigations place taurine at the intersection of inflammation control, metabolic regulation, and regenerative medicine, including diabetic wound healing, diabetic nephropathy, oral ulcer therapy, and cellular senescence research.

Focus of Latest Publications

Recent publications on taurine have focused on its roles as a therapeutic adjunct, a metabolic modulator, and a component of biomaterial-based delivery systems across aging, inflammatory, renal, wound-healing, and cellular senescence contexts. In a phase II randomized controlled trial protocol, taurine supplementation is being evaluated for effects on metabolic health and biological aging in healthcare workers, motivated by experimental evidence suggesting that taurine deficiency contributes to age-related metabolic disease. In another aging-related study, combined metformin and taurine treatment was investigated for its potential to attenuate age-related bone loss and preserve bone marrow mesenchymal stem cell function. In lung fibroblasts and aged mouse lungs, exogenous taurine supplementation was reported to restore PEX5 levels, mitigate senescence phenotypes, and participate in a PEX5-taurine-PEX5 positive feedback loop linked to p38 MAPK signaling, TFEB nuclear translocation, and autophagic flux.

Several studies examined taurine in inflammatory and tissue-repair settings. In streptozotocin-induced diabetic mice, taurine attenuated diabetic nephropathy by reducing blood glucose, inflammatory cell infiltration, serum creatinine and urea nitrogen, and inflammatory mediators including IL-6, IL-1β, and TNF-α, while also suppressing the HMGB1/TLR4/MyD88/NF-κB axis and restoring podocyte marker expression. In diabetic wound healing, taurine was delivered together with insulin in a self-healing, pH/glucose-responsive hydrogel, where the system improved glucose consumption, reduced Intracellular ROS, increased collagen synthesis, promoted fibroblast and keratinocyte proliferation, and accelerated wound closure in diabetic mice. Taurine was also incorporated into protocatechualdehyde-taurine nanoparticles for oral ulcer therapy, where the resulting material scavenged free radicals, neutralized lipopolysaccharide, protected mitochondria, modulated macrophage polarization, and shortened ulcer healing time in an animal model.

Taurine also appeared in studies of cancer metabolism and immune resistance. Using mass spectrometry imaging integrated with a tumor organoid-immunity platform, taurine was among the metabolites mapped within colorectal cancer organoids exposed to immune cells. This work showed that immune-resistant organoids had distinct metabolic adaptations, including marked phospholipid reprogramming and preservation of a larger phospholipid pool under immune pressure, while also highlighting taurine, glutathione, and fatty acid metabolism as part of the broader metabolic landscape examined in the platform. The study did not assign taurine a standalone causal role, but placed it within the metabolic profiling of immune-sensitive and immune-resistant tumor states.

Overall, the recent literature portrays taurine as a multifunctional molecule studied in contexts ranging from systemic supplementation to targeted biomaterial delivery and mechanistic cell biology. Across these publications, taurine was linked to modulation of inflammation, oxidative stress, insulin resistance, senescence, and tissue repair, with reported benefits in preclinical models of kidney disease, wound healing, oral mucosal injury, and aging-related dysfunction.

Key Publications

NEWJul Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease. (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026, PMID 42373580): "Clarifying the relationship between fluid tau species and tau PET in AD may allow for the identification of fluid biomarkers that could serve as more accessible surrogates for tau PET."
NEWJul Elimination of tau tangles and soluble aggregates with the small molecule ACI-16664 prevents neurodegeneration in vivo. (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026, PMID 42363714): "Pathological tau aggregates are key therapeutic targets in Alzheimer's disease (AD), but current approaches face limitations including poor intracellular penetration, lack of selectivity for aggregated over physiological tau, or reliance on invasive administration."
NEWJun Combined metformin and Taurine attenuate age-related bone loss. (Molecular biology reports, 2026, PMID 42364025): "This study aimed to investigate whether combined Metformin and Taurine (Met + Ta) treatment could attenuate aging-associated skeletal deterioration and preserve BMSC function."
NEWJun Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic. (Metabolic brain disease, 2026, PMID 42360686): "No correlations were found between adiponectin (plasma total and HMW, and CSF total) and CSF amyloid or tau biomarkers."
May Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trial. (PloS one, 2026, PMID 42201902): "Recent experimental evidence suggests that taurine (2-aminoethanesulfonic acid) deficiency contributes to these conditions, despite taurine being classified as a conditionally essential amino acid."
Apr Natural polyphenol-taurine-based nanoparticles for oral ulcer therapy. (Journal of materials chemistry. B, 2026, PMID 41989033): "Here, we report a one-step oxidative copolymerization strategy to synthesize pH/ROS dual-responsive protocatechualdehyde taurine nanoparticles (PAT NPs) by cross-linking protocatechualdehyde and taurine (Tau)."
Jun A self-healing, pH/glucose-responsive carboxymethyl chitosan and oxidized bacterial nanocellulose hydrogel for insulin and taurine delivery in diabetic wound healing. (Carbohydrate polymers, 2026, PMID 41943357): "...for insulin (INS) and taurine (Tau) delivery."
Apr Integrating Mass Spectrometry Imaging with Tumor Organoid-Immunity Platform to Identify Metabolic Adaptations in Tumor Immune Resistance. (Analytical chemistry, 2026, PMID 41920069): "...we achieved in situ MSI mapping of phospholipids, fatty acids, taurine, glutathione, and other metabolites within tumor organoids."
May Taurine attenuates diabetic nephropathy by suppressing the HMGB1/TLR4/MyD88/NF-κB axis in mice. (International immunopharmacology, 2026, PMID 41864015): "The scope of this investigation was to explore possible prophylaxis effects of taurine on DN from the perspective of TLR4/NF-κB signaling transductions and inflammation inhibition."
May PEX5 integrates the p38 MAPK signaling pathway and taurine metabolism to regulate senescence in lung fibroblasts. (Experimental cell research, 2026, PMID 41794210): "Metabolomic profiling revealed that PEX5 overexpression enhanced taurine biosynthesis by facilitating the peroxisomal localization of its key synthetic enzymes."